Jared Gilman, MD
Pain Medicine · Tucson, AZNPI 1801240569
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (48.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medtronic at 38.7% of the total. Reporting peaked in 2020 at $20,127 and has fallen 89.8% since, to $2,062 in 2025. Among pain medicine clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 488 payments — averaging $82.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Kowa Pharmaceuticals America, Inc.$8K
- Boston Scientific$7K
- Nalu Medical, Inc.$4K
- Abbott$2K
- Saluda Medical Americas, Inc.$1K
- plus $3K from 20 others
What the payments were for
- Speaking & faculty fees$7,00017%
- Grants$19,30348%
- Travel & lodging$2,0765%
- Food & beverage$11,83029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 9 | $15,565 |
| Kowa Pharmaceuticals America, Inc. | 8 | $7,549 |
| Boston Scientific | 61 | $6,619 |
| Nalu Medical, Inc. | 123 | $4,042 |
| Abbott | 116 | $1,857 |
| Saluda Medical Americas, Inc. | 55 | $1,166 |
| Stryker | 5 | $819 |
| Collegium Pharmaceutical, Inc. | 54 | $728 |
| Vertos Medical, Inc. | 12 | $509 |
| Nevro Corp. | 10 | $415 |
| SPR Therapeutics, Inc | 11 | $234 |
| Merz Pharmaceuticals, LLC | 3 | $127 |
| AbbVie | 1 | $127 |
| Relievant Medsystems, Inc. | 1 | $108 |
| Globus Medical | 4 | $68 |
| Valinor Pharma, LLC | 3 | $57 |
| Foundation Fusion Solutions, LLC | 2 | $45 |
| Averitas Pharma Inc. | 2 | $29 |
| Bioventus LLC | 1 | $28 |
| Spinal Simplicity, LLC | 1 | $22 |
| Avanos Medical | 1 | $19 |
| Tonix Medicines, Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Acacia Pharma Inc | 1 | $15 |
| Vertex | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$15,000
- Seglentis$7,544
- SPECTRA WAVEWRITER$4,303
- Nalu Neurostimulation System$1,765
- SPINEJACK$688
- RESTORE$450
- mild Device Kit$385
- Evoke$353
- Senza$270
- BOTOX$127
- Intracept$108
- ETERNA$103
- ARTISAN$100
How this compares
$40,208 in reported general payments places this provider in the 90th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 28 | $22,928 |
| Buprenorphine | 43 | $10,781 |
| Xtampza ErOxycodone Myristate | 12 | $6,990 |
| MovantikNaloxegol Oxalate | 13 | $5,372 |
| Gabapentin | 268 | $3,565 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 120 | $3,555 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 87 | $2,964 |
| Oxycodone Hcl | 180 | $2,857 |
| Pregabalin | 117 | $2,791 |
| Celecoxib | 24 | $1,490 |
| Methocarbamol | 62 | $1,414 |
| Baclofen | 81 | $1,344 |
| Lidocaine | 13 | $1,202 |
| Tizanidine Hcl | 163 | $1,180 |
| Duloxetine Hcl | 65 | $1,118 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $728 | $29,91840 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 180 pain medicine providers in Arizona.
Other pain medicine in Tucson
- Eric CornidezTucson$496K
- Efrain CubilloTucson$37K
- Kayven FarshadTucson$27K
- Jared WilsonTucson$26K
- Christopher BenhatzelTucson$16K
- Marco DuranTucson$15K
- Steven PrustTucson$15K
- Christopher BaileyTucson$13K
- Khushvant BholaTucson$13K
- Kenneth GosslerTucson$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.